Cite

HARVARD Citation

    Popov, J. et al. (2011). Multivalent rituximab lipid nanoparticles as improved lymphoma therapies: indirect mechanisms of action and in vivo activity. Nanomedicine. pp. 1575-1591. [Online]. 
  
Back to record